Nearly two-thirds of ovarian cancer patients don’t receive recommended treatment that could extend their lives, U.S. researchers have found. For patients who didn’t get care that follows the National Comprehensive Cancer Network clinical practice guidelines, the risk of dying within five years of follow-up was 30 percent greater compared to women who got recommended treatment, said researcher Dr.
